Evidence map›Paper›PMID 42907970›Full record

ArticleBMC microbiology2026

Co-occurrence of bla

Yali Zheng, Zhouguang Jiao, Xin Lin, Yu Zhang, Jianbo Ye, Jian Lan, Huimin Chen, Xinhua Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yali Zheng *Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Zhouguang Jiao *Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-Autoimmune Disease of Hebei Province, College of Basic Medical Sciences, Hebei University, Baoding, 071000, China.
Xin LinShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yu ZhangSchool of Life Sciences, Suzhou Medical College of Soochow University, Suzhou, China.
Jianbo YeDepartment of Laboratory MedicineSchool of MedicineTaizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Jian LanDepartment of Critical Care Medicine, School of Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, China.
Huimin ChenDepartment of Laboratory MedicineSchool of MedicineTaizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Xinhua LuoDepartment of Laboratory MedicineSchool of MedicineTaizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China. luoxiangnanchang84@163.com.

Funding

Medical and Health Science and Technology Project of Zhejiang Province 2025KY461Natural Science Foundation of Zhejiang Province LTGY23H190003
6 · The paper itself

Abstract

backgroundKlebsiella grimontii is a recently confirmed member of the Klebsiella oxytoca complex with significant clinical importance. As an opportunistic pathogen, reports of infections it causes are increasing, and the associated threats warrant attention. However, its phylogeny and epidemiological patterns remain poorly studied.

methodsIn this study, we identified a strain of Klebsiella grimontii, designated K767, simultaneously carrying the carbapenemase genes bla

resultsGenomic analysis revealed that in strain K767, bla

conclusionThis study reports a strain of Klebsiella grimontii simultaneously carrying bla

Indexed as

Bacterial Proteinsbeta-LactamasesKlebsiellaKlebsiella InfectionsAnti-Bacterial AgentsChinaEvolution, MolecularGenome, BacterialGenomicsHumansMicrobial Sensitivity TestsPhylogenyPlasmidsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase IMP-4beta-LactamasesBla IMP-4Bla KPC-2Carbapenemase genesGlobal population analysisKlebsiella grimontiiSequence types

Identifiers

PMID42907970
PMCPMC13685131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.